companydata.dkEvosep ApS: Financial statements 2016
CVR: 37510068
Evosep ApS (CVR 37510068) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -1,203,028 and a net result of DKK -4,195,093. Equity amounted to DKK 7,854,787. The solvency ratio was 90.2%.
- Gross Profit
- -1,203,028 kr.
- Profit/Loss
- -4,195,093 kr.
- Equity
- 7,854,787 kr.
- Total Assets
- 8,707,932 kr.
How creditworthy is Evosep ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of June 30, 2016, Ole Vorm has joined the board of directors of Evosep ApS.
As of June 30, 2016, Tonni Bülow-Nielsen has joined the board of directors of Evosep ApS.
As of June 30, 2016, Ole Vorm is registered as adm. dir. of Evosep ApS.
On June 30, 2016, the company changed its name from Omics Ready Biosystems ApS to Evosep ApS.
As of June 29, 2016, Ole Vorm has stepped down as director of Evosep ApS.
As of March 1, 2016, DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Evosep ApS.
As of March 1, 2016, Ole Vorm is registered as director of Evosep ApS.
Evosep ApS was founded on March 1, 2016.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.